Sutro Biopharma, Inc. (STRO)
13.82
+0.75
(+5.74%)
USD |
NASDAQ |
Jan 16, 16:00
13.84
+0.02
(+0.14%)
After-Hours: 20:00
Sutro Biopharma SG&A Expense (TTM): 41.39M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| GT Biopharma, Inc. | 6.564M |
| Daré Bioscience, Inc. | 9.228M |
| Syndax Pharmaceuticals, Inc. | 167.44M |
| Crinetics Pharmaceuticals, Inc. | 165.81M |
| NovaBay Pharmaceuticals, Inc. | 8.584M |